Moodle
You are not logged in. (Login)
Skip Check this out...
Show or hide block

Check this out...


Welcome to E-Menai

10 ambien is a specialty pharmaceutical company focused primarily in the area of cardiology.S. The APR products and technologies are licensed to third parties for distribution and marketing activities. Acurox utilizes Acura's proprietary Aversion Technology, which is designed to deter misuse and abuse by intentional swallowing of excess quantities of tablets, intravenous injection of dissolved tablets and nasal snorting of crushed tablets. The 10 ambien Acurox Tablets NDA was originally accepted for filing by FDA earlier this year with a priority review classification. About King Pharmaceuticals, Inc. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements.

.


NewsA Level

S. "The approval is the culmination of over three years of effort from our partners at Applied Pharma Research and the internal team at Kowa," said William Maichle, Chief Operating Officer of Kowa Pharmaceuticals America, Inc." KPA obtained exclusive U. KPA and APR are currently in the final stages of negotiations with a marketing partner and expect Cambia to launch in 4th quarter 2009. PALATINE, Ill..